![Zachary Hornby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zachary Hornby
Directeur des opérations chez
Ignyta Operating, Inc.
Fortune : 641 025 $ au 30/06/2026
Profil
Zachary D.
Hornby currently works at Novome Biotechnologies, Inc., as Director from 2021, Independa, Inc., as Director, Radionetics Oncology, Inc., as Director, Ignyta Operating, Inc., as Chief Operating Officer from 2014, and City Hill Ventures LLC, as Operating Partner.
Mr. Hornby also formerly worked at Boundless Bio, Inc., as President, Chief Executive Officer & Director from 2019 to 2026, Fate Therapeutics, Inc., as Senior Director-Business Development from 2010 to 2012, Halozyme Therapeutics, Inc., as Director-Business Development from 2008 to 2010, Aardvark Therapeutics, Inc., as Director, Ignyta, Inc., as Chief Operating Officer from 2014 to 2018, Shire Pharmaceuticals, Inc., as Business Development Associate, Neurocrine Biosciences, Inc., as Senior Manager-Products from 2006 to 2008, Ignyta, Inc., as Chief Operating Officer & Vice President in 2018, and The Lek, as Life Sciences Consultant.
Mr. Hornby received his undergraduate degree in 2001 and graduate degree in 2001 from Stanford University and Masters Business Admin degree in 2006 from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BOUNDLESS BIO INC. 1,14 % | 20/04/2026 | 256 410 ( 1,14 % ) | 641 025 $ | 30/06/2026 |
Postes actifs de Zachary Hornby
| Sociétés | Poste | Début |
|---|---|---|
Ignyta Operating, Inc.
 Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular diagnostics for cancer and immunology | Directeur des opérations | 01/08/2012 |
Independa, Inc.
 Independa, Inc. Packaged SoftwareTechnology Services Provides solutions that support independence as we age | Directeur/Membre du Conseil | - |
City Hill Ventures LLC
 City Hill Ventures LLC Investment ManagersFinance City Hill Ventures invests in companies located in the United States. The firm focuses on biotechnology, clean technology and media & entertainment sectors and industries. It participates in seed, early and later stage capital requirements with an investment size ranging from USD 0.1 to 20 million. It also makes co- investments. | Private Equity Investor | - |
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics through the engineering of commensal gut microbes | Directeur/Membre du Conseil | 26/05/2021 |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that discovers and develops novel radio therapeutics for the treatment of oncology indications | Directeur/Membre du Conseil | - |
Anciens postes connus de Zachary Hornby
| Sociétés | Poste | Fin |
|---|---|---|
| BOUNDLESS BIO, INC. | Directeur Général | 01/07/2026 |
| AARDVARK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2024 |
| IGNYTA INC | Directeur des opérations | 01/07/2018 |
| IGNYTA INC | Directeur Financier/CFO | 30/05/2014 |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Zachary Hornby
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Independa, Inc.
Independa, Inc. Packaged SoftwareTechnology Services Provides solutions that support independence as we age | Technology Services |
Ignyta Operating, Inc.
Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular diagnostics for cancer and immunology | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
City Hill Ventures LLC
City Hill Ventures LLC Investment ManagersFinance City Hill Ventures invests in companies located in the United States. The firm focuses on biotechnology, clean technology and media & entertainment sectors and industries. It participates in seed, early and later stage capital requirements with an investment size ranging from USD 0.1 to 20 million. It also makes co- investments. | Finance |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. BiotechnologyHealth Technology Develops cell-based therapeutics through the engineering of commensal gut microbes | Health Technology |
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
Boundless Bio, Inc.
 Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
Radionetics Oncology, Inc.
Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that discovers and develops novel radio therapeutics for the treatment of oncology indications | Health Technology |
